These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23360700)

  • 21. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
    Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
    Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
    Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
    Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic breast cancer epidemiology and management with a focus on taxanes.
    Donovan D
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():5-8. PubMed ID: 23360697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy: A Brief Report.
    Ben-Arye E; River Y; Keshet Y; Lavie O; Israeli P; Samuels N
    Int J Gynecol Cancer; 2018 Jun; 28(5):1045-1049. PubMed ID: 29561303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
    Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
    Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
    Rizzo R; Spaggiari F; Indelli M; Lelli G; Baricordi OR; Rimessi P; Ferlini A
    Breast Cancer Res Treat; 2010 Nov; 124(2):593-8. PubMed ID: 20632082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
    Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
    Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
    Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of taxane neuropathy.
    Kudlowitz D; Muggia F
    Anticancer Drugs; 2014 May; 25(5):495-501. PubMed ID: 24300917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM1 for taxane-induced neuropathy in breast cancer.
    Das M
    Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
    [No Abstract]   [Full Text] [Related]  

  • 31. Taxane induced neuropathy in patients affected by breast cancer: Literature review.
    De Iuliis F; Taglieri L; Salerno G; Lanza R; Scarpa S
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):34-45. PubMed ID: 26004917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
    Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
    Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxanes in elderly breast cancer patients.
    Wildiers H; Paridaens R
    Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.
    Davis AL; Klitus M; Mintzer DM
    Clin Breast Cancer; 2005 Dec; 6(5):421-4. PubMed ID: 16381625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
    Andersen Hammond E; Pitz M; Shay B
    Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
    Smith EM; Cohen JA; Pett MA; Beck SL
    Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.
    Wilkes GM
    Oncology (Williston Park); 2010 Oct; 24(10 Suppl):46-8. PubMed ID: 21275327
    [No Abstract]   [Full Text] [Related]  

  • 38. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.